Medvolt

Medvolt's Pipeline

DIVERSIFIED PIPELINE
DISCOVERED USING MedGraphTM

Medvolt.ai

Reach out to us at contact@medvolt.ai for partnering opportunities

  • Indication
    Target
    Type
    Stage
  • Pan-Oncology (Breast, Prostate, Ovarian Cancer)
    Undisclosed*
    NCE
    Pre-DiscoveryDiscoveryPre-Clinical / IND-enablingClinical
  • Triple Negative Breast Cancer (TNBC)
    Undisclosed*
    RPE
    Pre-DiscoveryDiscoveryPre-Clinical / IND-enablingClinical
  • Inflammatory Disorders
    Undisclosed*
    NCE
    Pre-DiscoveryDiscoveryPre-Clinical / IND-enablingClinical
  • Peptic Ulcer
    Undisclosed*
    RPE
    Pre-DiscoveryDiscoveryPre-Clinical / IND-enablingClinical

NCE :

New Chemical Entity

RPE :

Re-purposed Entity

Undisclosed* :

Programs across targets have advanced in various stages. More information on targets will be provided upon CDA

This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy